Related Experiment Video
Updated: Aug 4, 2025
12:46
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
2.6K
Immunopathogenesis and immunomodulatory therapy for myocarditis
Wu He1,2, Ling Zhou1,2, Ke Xu1,2
1Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Science China. Life Sciences
|March 31, 2023
Summary
Myocarditis, an inflammatory heart condition, is increasingly linked to new pathogens, drugs, and vaccines. Understanding its immunopathogenesis is key to developing effective immunomodulatory therapies.
Area of Science:
- Cardiology
- Immunology
- Pathology
Background:
- Myocarditis is an inflammatory cardiac disease causing myocardial cell destruction, inflammation, and fibrosis, posing a growing public health challenge.
- Emerging pathogens, drugs, and vaccines, including COVID-19 vaccines and immune checkpoint inhibitors, are expanding the known causes of myocarditis.
- Immunopathological mechanisms are crucial in myocarditis development, progression, and outcomes, influencing disease severity and long-term effects.
Purpose of the Study:
- To review the current understanding of the causes and immune mechanisms of myocarditis.
- To explore the association between recent medical advancements and myocarditis.
- To offer novel perspectives on immunomodulatory treatment strategies for myocarditis.
Main Methods:
- This review synthesizes existing literature on myocarditis.
- It examines the role of immunopathological processes in disease pathogenesis.
- The review analyzes current and potential immunomodulatory therapies.
Main Results:
- Excessive immune activation can lead to severe myocardial injury and fulminant myocarditis.
- Chronic inflammation contributes to cardiac remodeling and inflammatory dilated cardiomyopathy.
- The efficacy and use of immunosuppressive treatments for myocarditis remain debated, with a trend towards immunomodulatory approaches.
Conclusions:
- A comprehensive understanding of myocarditis etiology and immunopathogenesis is essential.
- Immunomodulatory therapies represent a promising direction for managing myocarditis.
- Further research into targeted immunomodulation is needed to improve patient outcomes.
Related Concept Videos
01:21Myocarditis I: Introduction
14
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
14
01:14Myocarditis III: Medical Management
10
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
10
01:27Myocarditis II: Clinical Features and Diagnostic Tests
14
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
14
01:22Myocarditis IV: Nursing Management
14
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
14
01:29Cardiomyopathy V: Interprofessional Care
20
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
20
01:17Pericarditis III: Medical Management
18
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
18